Portfolio company
Genis
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Genis manufactures therapeutic chitin derivatives for medical researchers and healthcare providers to treat inflammatory diseases and assist in bone tissue regeneration.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
GeniPhys
This company develops polymerisable collagen scaffolds for tissue restoration and wound management for medical patients and healthcare providers.
Gentis
This company developed an injectable biomaterial implant to restore biomechanical function in degenerated spinal discs for patients with spinal disc disease.
Genhtis
Genhtis develops infrastructure-grade pharmaceutical manufacturing capacity to secure the supply of critical medicines for hospitals.
IBI
This company develops and manufactures biomimetic bone substitutes for orthopaedic and dental surgeons to support bone tissue regeneration.
Generare
This company develops a discovery platform that generates molecular data from microbial genomes for pharmaceutical and crop protection companies to advance drug and product development.
Artis BioSolutions
The company produces synthetic DNA and manufacturing services for biotechnology and pharmaceutical firms developing genetic medicines and advanced therapies.
GreenBone
This company produces rattan wood-derived bone substitutes for adult patients undergoing orthopedic surgery to treat severe bone defects and fractures.
CuroTis
This biotechnology company develops regenerative grafts that stimulate the body to grow patient-specific blood vessels for individuals requiring vascular access or organ regeneration.
